TSTickerStarGet alerts

IM Cannabis Reports Q3 and Nine-Month 2026 Results; Revenue Declines 68% Year-Over-Year

IM Cannabis Corp. reported Q3 2026 revenue from continuing operations of $1.65 million, a 68% decline from $5.08 million in Q3 2025, with the company reporting a gross loss of $0.04 million compared to gross profit of $1.58 million in the prior-year period. Net loss for Q3 2026 was $7.08 million or $6.69 per share, compared to a net loss of $3.87 million or $0.44 per share in Q3 2025. For the nine months ended September 30, 2026, revenue from continuing operations decreased 43% to $8.96 million from $15.77 milli...

Share this story

Key takeaways

  • Q3 2026 revenue from continuing operations was $1.65 million, down 68% year-over-year from $5.08 million, driven by variations in product mix, pricing, volume, and reduced imports due to cash flow constraints

  • Q3 2026 gross loss from continuing operations was $0.04 million versus gross profit of $1.58 million in Q3 2025, with gross margin declining to negative 2% from positive 31%

  • Q3 2026 net loss was $7.08 million or $6.69 per share, compared to net loss of $3.87 million or $0.44 per share in the prior-year period

  • Nine-month 2026 revenue from continuing operations was $8.96 million, down 43% from $15.77 million in the prior-year period

  • Company completed sale of IMC Holdings to Slil.com Holding Ltd. on September 29, 2026, with Slil assuming liabilities not to exceed $9.4 million; the company recognized a gain of $2.7 million on disposal

  • Company entered into non-binding LOI to acquire 51% of Space Defense Innovations LLC, a Polish unmanned aerial systems distributor, on September 23, 2026

  • Company regained compliance with Nasdaq minimum bid price requirement in September 2026 following a 30:1 reverse share split on August 27, 2026

Key metrics

Revenue from continuing operationsQ3 2026 and Nine months ended September 30, 2026
$1.65 million (Q3 2026), $8.96 million (9M 2026)Q3: -68% YoY; 9M: -43% YoY
Revenue from continuing operations (Q3 2025)Q3 2025
$5.08 million
Revenue from continuing operations (9M 2025)Nine months ended September 30, 2025
$15.77 million
Gross profit (loss) from continuing operationsQ3 2026 and Nine months ended September 30, 2026
$(0.04) million (Q3 2026), $1.33 million (9M 2026)Q3: from $1.58 million profit to $(0.04) million loss; 9M: from $4.87 million to $1.33 million
Net loss from continuing operationsQ3 2026 and Nine months ended September 30, 2026
$4.67 million (Q3 2026), $10.83 million (9M 2026)Q3: from $2.35 million loss to $4.67 million loss; 9M: from $2.59 million loss to $10.83 million loss
Net loss (total)Q3 2026 and Nine months ended September 30, 2026
$7.08 million (Q3 2026), $13.93 million (9M 2026)Q3: from $3.87 million loss to $7.08 million loss; 9M: from $3.88 million loss to $13.93 million loss
Basic and diluted loss per share from continuing operationsQ3 2026 and Nine months ended September 30, 2026
$6.69 (Q3 2026), $25.90 (9M 2026)Q3: from $0.44 to $6.69; 9M: from $0.64 to $25.90
Total basic and diluted loss per shareQ3 2026 and Nine months ended September 30, 2026
$10.15 (Q3 2026), $33.51 (9M 2026)Q3: from $0.75 to $10.15; 9M: from $0.99 to $33.51

Primary source

TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.

Open SEC filing

Follow IMCC in real time

Get material earnings, filing, IR, and earnings-call alerts by email.

Create a free alert